Drug Developmentby drdasarajuSeptember 6, 2024September 30, 2024 1. To avoid bias, clinical trials should be Controlled, non-randomised and single-blind Controlled, randomised and double-blind Controlled, non-randomised and double-blind Controlled, randomised and single-blind None 2. Placebos in clinical trials are used in Phase 1 Phase 3 Phases 2 and 3 Phase 2 None 3. Which of the following statement is incorrect? Dose-related adverse drug reactions are a particular concern when drugs have a narrow therapeutic index Patent time period for a new drug usually begins from the time of approving investigational new drug In pharmacokinetic interactions, a drug alters the metabolism or excretion of another drug Quantal dose-response curves are used to determine maximal efficacy of a drug None 4. When does the patent time period for a new compound begin? When phase II is completed and shows efficacy in humans When the FDA approves an investigational new drug application When the FDA approves the drug for marketing When phase 1 of the clinical study is completed and shows safety in humans None 5. Essential drugs are Life saving drugs Drugs that are used in medical emergencies Drugs that are listed in the pharmacopoeia of a country Drugs that meet the priority health care needs of the population None Time's up Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Name * Email * Website Comment * Save my name, email, and website in this browser for the next time I comment. Δ
